Global Invitro Diagnostics Market 2009-2013

Innovations and advancement in various Invitro Diagnostics (IVD) technologies (including molecular biology, immunoassays, etc) have led to the development of new diagnostics test applications, resulting in a phenomenal growth of the IVD market. The adoption of these diagnostics tests has eliminated the need for certain cumbersome traditional diagnostic procedures. Moreover, health awareness among people has increased with the availability of better medical and health information. Moreover, the expectation for information through diagnosis has risen with more number of people becoming aware of new technologies. In turn, this has motivated the healthcare organizations to adopt innovative and advanced IVD devices or tests for a swift diagnosis and an efficient treatment.
The IVD market is witnessing a phenomenal growth, which can be mainly attributed to the growth of emerging markets like molecular diagnostics, point of care devices, diabetes care, etc. The molecular diagnostics is one of the fastest growing segments of the IVD industry, and is estimated to show a tremendous growth over the next few years. Further, the increasing growth rates of infectious diseases, aging and chronically ill population, diabetes, etc is favoring the growth of the IVD market. In the future, the competition in the market and increasing patient population will account for a further growth of novel technology in the IVD industry.
Further, the emerging sectors like genetic testing hold tremendous opportunities in the field of molecular diagnostics, theragnostics, and personalized medicine. Such advancements are likely to lead to the development of high-value diagnostic tests for oncology, cardiovascular , genetic and infectious diseases.
The report by TechNavio Insights forecasts the market size of the worldwide In Vitro Diagnostics market over the period 2009-2013. Further, the report discusses about the segmentation of the In Vitro Diagnostics market into various geographic regions. It also identifies the major market trends, drivers, and challenges existing in the IVD market.


Report Highlights

[Cerrar las informaciones del articulo de mercado]

1. Introduction
2. In Vitro Diagnostics Market Size & Forecast
3. Geographic Segmentation
3.1 In Vitro Diagnostics Market in Americas
3.2 In Vitro Diagnostics Market in EMEA
3.3 In Vitro Diagnostics Market in APAC
4. Market Trends of In Vitro Diagnostics
5. Drivers of In Vitro Diagnostics Market
6. Market Challenges for In Vitro Diagnostics
7. In Vitro Diagnostics Market Vendors
7.1 Abbott Laboratories
7.2 Bayer Healthcare AG
7.3 Beckman Coulter, Inc
7.4 Johnson & Johnson
7.5 Roche Holding AG
7.6 Siemens Healthcare
Other Vendors:
Other Reports in this Series

List of Exhibits

Exhibit 2.1: In Vitro Diagnostics Market Size and Forecast 2009-2013 (In $ million)
Exhibit 3.1: In Vitro Diagnostics Market Segmentation by Geography -2009
Exhibit 3.2: Americas In Vitro Diagnostics Market Size 2009-2013 (in $ million)
Exhibit 3.3: EMEA In Vitro Diagnostics Market Size 2009-2013 (in $ million)
Exhibit 3.4: APAC In Vitro Diagnostics Market Size 2009-2013 (in $ million)

[Cerrar la tabla de contenidos]